Abstract: A device for bending an intraocular lens with an optical part which is flexible, before the lens is implanted, includes at least one pair of bending support surfaces, which are designed to be able to be placed in contact with the optical part of the lens, in two areas of contact which are opposite according to a single diametral direction, and a part for maneuvering, which are designed such that, with a lens in place in a part for reception, according to a first method for actuation, two bending support surfaces come into contact with the optical part of the lens, for bending according to a first bending line, and, according to at least a second method for actuation, two other bending support surfaces come into contact with the optical part of the lens, for bending according to a second bending line, which is distinct from the first bending line. The lens can be bent according to one or the other of the bending lines.

Abstract: The invention concerns a monobloc intraocular lens made of a flexible material comprising a central optic part (1) and a haptic part (4) including two loops (5) in contact with an internal wall of the eye and, for each contact loop (5), two elements (10, 10′) to be linked with the optic part (1), the lens having a symmetry with respect to two perpendicular axes (6, 8), the external surface (9) of each contact loop (5) having a convex-shaped curve defining an apex (S), and two end points (E, E′). The circle (Ca) passing through the apex (S) and the two end points (E, E′) has a diameter &phgr;a greater than or equal to the mean diameter &phgr;m of the ocular housing, and less than &phgr;m+1.5 mm. The apices (S) are separated from each other by a distance D>&phgr;a and the linking elements (10, 10′) are adapted so as to be deformable in flexion in the principal plane (3) of the lens.

Abstract: The invention relates to novel fluorinated organic compounds having the following molecular structure: ##STR1## where R.sub.F is a fluorinated carbon chain, R.sub.1H is hydrogen or a saturated hydrogenated carbon chain, R.sub.2H is hydrogen or a saturated hydrogenated carbon chain, R.sub.1H and R.sub.2H being not simultaneously hydrogen, the group ##STR2## comprising a principal chain and at least one linear or cyclic branch. These compounds may be prepared by reacting a phosphine with a halide under heating, and then hot reacting in a solvent the resulting phosphonium salt with a branched aldehyde or a ketone. These compounds have an excellent stability, a good biocompatibility and a high capacity to solubilize gases and particularly oxygen, such properties allowing their use in applications of the ophthalmological type or as an organ preservation medium.

Abstract: A sclerotomy implant intended to be set in place in the sclera of the eye in order to provide for a continuous flow of aqueous humor through the trabecula for the treatment of a glaucoma. This implant is configured like a platelet made of biocompatible material and comprising an intrascleral portion (1) and a sub-conjuctival portion (5), the latter being adapted to come out of the sclera and penetrate under the conjunctiva. Retaining flanges (7a, 7b) provide for the blocking of the implant in the trap under the scleral flap. The implant comprises at least one continuous flow passage from its trabecular extremity (2) applied against the trabecula up to its external extremity (6) inserted in the conjunctiva.